Consistent with the finding that DNMT3A induces an aggressive phenotype of GBC in vitro, the in vivo tumor xenograft assay indicated that silencing DNMT3A inhibited GBC cell metastasis to the liver (Figure 3a,c). The gene discussed is DNMT3A; the disease is neoplasm.